Allspring Global Investments Holdings, LLC Collegium Pharmaceutical, Inc Transaction History
Allspring Global Investments Holdings, LLC
- $62.1 Billion
- Q3 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 79,822 shares of COLL stock, worth $2.36 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
79,822
Previous 43,491
83.54%
Holding current value
$2.36 Million
Previous $1.4 Million
120.29%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding COLL
# of Institutions
254Shares Held
36.9MCall Options Held
100KPut Options Held
21.1K-
Black Rock Inc. New York, NY5.79MShares$171 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$77.8 Million1.79% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.59MShares$76.4 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$69.2 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$48.9 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.01B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...